MyoKardia Inc - Company Profile

Powered by

All the sales intelligence you need on MyoKardia Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how MyoKardia Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with MyoKardia Inc.

Back to companies

MyoKardia Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

MyoKardia Inc is developing drugs for the treatment of hypertrophic cardiomyopathy. The company is headquartered in Brisbane, California, the US.

 Gain a 360-degree view of MyoKardia Inc and make more informed decisions for your business Gain a 360-degree view of MyoKardia Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 1000 Sierra Point Parkway, Brisbane, California, 94005
No of Employees 235
Industry Pharmaceuticals and Healthcare
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

MyoKardia Inc premium industry data and analytics

18+

Catalyst Calendar

Proactively evaluate MyoKardia Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

14+

Clinical Trials

Determine MyoKardia Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

9

Pipeline Drugs

Identify which of MyoKardia Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Marketed Drugs

Understand MyoKardia Inc’s commercialized product portfolio to stay one step ahead of the market.

Image for loader

Competitor Comparison

Key Parameters MyoKardia Inc Bayer AG Amgen Inc Novartis Corp Takeda Pharmaceuticals America Inc
Headquarters United States of America Germany United States of America United States of America United States of America
City Brisbane Leverkusen Thousand Oaks East Hanover Cambridge
State/Province California Nordrhein-Westfalen California New Jersey Massachusetts
No. of Employees 235 87,757 31,500 - -
Entity Type Private Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into MyoKardia Inc key executives to enhance your sales strategy Gain insight into MyoKardia Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?